rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2003-1-14
|
pubmed:abstractText |
Whether the risk of symptomatic hemorrhagic transformation (SHT) of cerebral infarction associated with the use of tissue plasminogen activator (t-PA) is higher in clinical practice than in clinical trials is unknown. The aim of this study was to analyze the safety profile and clinical outcome of patients with acute cerebral ischemia who received open treatment with t-PA in Spanish hospitals.
|
pubmed:commentsCorrections |
|
pubmed:language |
spa
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0025-7753
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
120
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12525296-Acute Disease,
pubmed-meshheading:12525296-Aged,
pubmed-meshheading:12525296-Brain Ischemia,
pubmed-meshheading:12525296-Disability Evaluation,
pubmed-meshheading:12525296-Female,
pubmed-meshheading:12525296-Fibrinolytic Agents,
pubmed-meshheading:12525296-Humans,
pubmed-meshheading:12525296-Infusions, Intravenous,
pubmed-meshheading:12525296-Male,
pubmed-meshheading:12525296-Prospective Studies,
pubmed-meshheading:12525296-Risk Factors,
pubmed-meshheading:12525296-Safety,
pubmed-meshheading:12525296-Thrombolytic Therapy,
pubmed-meshheading:12525296-Tissue Plasminogen Activator,
pubmed-meshheading:12525296-Tomography, X-Ray Computed,
pubmed-meshheading:12525296-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
[Intravenous tissue-type plasminogen activator for the treatment of acute cerebral ischemia].
|
pubmed:affiliation |
Servicio de Neurología y Unidad de Ictus. Hospital Universitari Josep Trueta. Girona. Spain. min.adavalos@htrueta.scs.es
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|